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dAlcohol Drinking and Cardiovascular Risk in a Population With
High Mean Alcohol Consumption
Maryline Foerster, MDa, Pedro Marques-Vidal, MD, PhDa,b, Gerhard Gmel, PhDd,e,
Jean-Bernard Daeppen, MDd, Jacques Cornuz, MD, MPHc, Daniel Hayoz, MDf, Alain Pécoud, MDc,
Vincent Mooser, MDh, Gérard Waeber, MDg, Peter Vollenweider, MDg, Fred Paccaud, MDa, and
Nicolas Rodondi, MD, MASc,*
Moderate alcohol consumption has been associated with lower coronary artery disease
(CAD) risk. However, data on the CAD risk associated with high alcohol consumption are
conflicting. The aim of this study was to examine the impact of heavier drinking on 10-year
CAD risk in a population with high mean alcohol consumption. In a population-based
study of 5,769 adults (aged 35 to 75 years) without cardiovascular disease in Switzerland,
1-week alcohol consumption was categorized as 0, 1 to 6, 7 to 13, 14 to 20, 21 to 27, 28 to
34, and >35 drinks/week or as nondrinkers (0 drinks/week), moderate (1 to 13 drinks/
week), high (14 to 34 drinks/week), and very high (>35 drinks/week). Blood pressure and
lipids were measured, and 10-year CAD risk was calculated according to the Framingham
risk score. Seventy-three percent (n  4,214) of the participants consumed alcohol; 16%
(n 909) were high drinkers and 2% (n 119) very high drinkers. In multivariate analysis,
increasing alcohol consumption was associated with higher high-density lipoprotein cho-
lesterol (from a mean  SE of 1.57  0.01 mmol/L in nondrinkers to 1.88  0.03 mmol/L
in very high drinkers); triglycerides (1.17  1.01 to 1.32  1.05 mmol/L), and systolic and
diastolic blood pressure (127.4  0.4 to 132.2  1.4 mm Hg and 78.7  0.3 to 81.7  0.9
mm Hg, respectively) (all p values for trend <0.001). Ten-year CAD risk increased from
4.31  0.10% to 4.90  0.37% (p  0.03) with alcohol use, with a J-shaped relation.
Increasing wine consumption was more related to high-density lipoprotein cholesterol
levels, whereas beer and spirits were related to increased triglyceride levels. In conclusion,
as measured by 10-year CAD risk, the protective effect of alcohol consumption disappears
in very high drinkers, because the beneficial increase in high-density lipoprotein cholesterol is
offset by the increases in blood pressure levels. © 2009 Elsevier Inc. (Am J Cardiol 2009;103:
361–368)
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nThe aim of this study was to assess the impact of heavier
rinking on lipids, blood pressure, high-sensitivity C-reac-
ive protein (hs-CRP), and 10-year coronary artery disease
CAD) risk in a population-based study in Switzerland in
ndividuals with high mean alcohol consumption.
ethods
This cross-sectional study examined participants in the Co-
orte Lausannoise (CoLaus) study, a population-based study of
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ospitalier Universitaire Vaudois, Lausanne, Switzerland; and hMedical Ge-
etics, GlaxoSmithKline, Philadelphia, Pennsylvania. Manuscript received
uly 10, 2008; revised manuscript received and accepted September 12,
008.
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tE-mail address: nicolas.rodondi@hospvd.ch (N. Rodondi).
002-9149/09/$ – see front matter © 2009 Elsevier Inc.
oi:10.1016/j.amjcard.2008.09.089,187 Caucasian community-dwelling men and women aged
5 to 75 years. Participants were selected from a random
ample of all age-eligible adults living in the city of Lausanne,
witzerland (population 117,161). The details of eligibility
riteria have been described previously.1 All participants gave
ritten informed consent and the institutional review board in
ausanne approved the protocol. All participants were inter-
iewed and examined at the clinical center from summer 2003
o spring 2006.
We further excluded 411 participants with cardiovascu-
ar disease, defined as a self-reported diagnosis of CAD
angina, previous myocardial infarction, percutaneous cor-
nary angioplasty, or coronary artery bypass graft), stroke,
r peripheral arterial disease. We also excluded 7 partici-
ants with missing variables for alcohol consumption. The
nal sample for our analysis was 5,769.
Participants reported whether they currently consumed
lcohol and how many standard drinks they had consumed
n the past 7 days, using the same method as other studies.2,3
standard drink was defined as a glass of wine, a bottle of
eer, or a shot of spirits, approximating 10 to 12 g of
thanol.4,5 Subjects were then categorized according to the
umber of drinks per week: 0, 1 to 6, 7 to 13, 14 to 20, 21
o 27, 28 to 34, and35 drinks/week. An alternative 4-level
www.AJConline.org
Table 1
Participant characteristics according to alcohol consumption of the previous 7 days (n  5,769)
Characteristic All Subjects Alcohol Use (Drinks in the Past Week) p Value p Value
for Trend
0 1–6 7–13 14–20 21–27 28–34 35
n 1,555 2,051 1,135 567 241 101 119
Age (yrs) 52.5  10.6 52.1  10.8 51.9  10.6 52.8  10.7 53.9  10.7 53.2  9.8 53.3  10.0 54.0  10.7 0.001 0.02
Women 3,076 (53%) 1,134 (73%) 1,237 (60%) 483 (43%) 151 (27%) 45 (19%) 13 (13%) 13 (11%) 0.001 0.001
Physical activity (min/wk) 64.3  50.9 65.6  55.2 62.2  41.5 64.8  48.7 67.5  60.1 65.8  62.8 65.8  77.6 58.5  55.5 0.20 0.47
Diabetes mellitus* 252 (4%) 84 (5%) 75 (4%) 46 (4%) 21 (4%) 10 (4%) 8 (8%) 8 (7%) 0.06 0.10
Hypertension† 2,035 (35%) 546 (35%) 622 (30%) 372 (33%) 246 (43%) 116 (48%) 56 (56%) 77 (65%) 0.001 0.001
Body mass index (kg/m2) 25.7  4.5 26.5  0.1 25.4  0.1 25.3  0.1 25.2  0.2 25.5  0.3 25.8  0.4 25.8  0.4 0.001 0.47
Education (yrs) 13.1  4.3 12.1  4.4 13.6  4.2 13.7  4.1 13.0  4.6 12.8  4.0 13.6  4.9 12.7  4.3 0.001 0.53
Smoking status 0.001 0.001
Never 2,358 (41%) 828 (53%) 901 (44%) 386 (34%) 156 (28%) 50 (21%) 18 (18%) 19 (16%)
Former 1,840 (32%) 388 (25%) 671 (33%) 420 (37%) 212 (37%) 76 (32%) 35 (35%) 38 (32%)
Current 1,571 (27%) 339 (22%) 479 (23%) 329 (29%) 199 (35%) 115 (48%) 48 (48%) 62 (52%)
Self-reported alcohol consumption
Standard no. of drinks/wk
Wine 6.9  7.1 2.7  1.7 6.9  2.8 12.0  4.5 15.3  6.2 20.8  8.0 28.9  15.2 0.001 0.001
Beer 1.9  4.4 0.5  1.0 1.4  2.2 3.0  4.2 5.3  6.1 7.2  7.7 13.6  13.6 0.001 0.001
Spirits or liquor 0.7  2.3 0.2  0.8 0.7  1.7 1.0  2.3 2.2  3.7 2.0  3.2 3.9  8.1 0.001 0.001
% of total consumption
Wine 76.7  31.0 79.3  33.3 76.9  28.3 75.5  28.2 67.3  27.4 69.1  26.6 62.7  28.5 0.001 0.001
Beer 15.9  26.2 13.5  27.6 15.4  22.8 18.1  24.8 23.1  26.5 24.2  25.9 29.0  27.5 0.001 0.001
Spirits or liquor 7.4  19.0 7.2  21.3 7.7  17.9 6.4  14.3 9.7  15.6 6.7  10.5 8.4  17.3 0.29 0.30
Abnormal total CDT‡ 330 (6%) 12 (1%) 30 (2%) 62 (6%) 77 (14%) 71 (31%) 28 (28%) 50 (45%) 0.001 0.001
Abnormal asialotransferrin§ 92 (2%) 4 (0.3%) 5 (0.3%) 11 (1%) 20 (4%) 21 (9%) 12 (12%) 19 (17%) 0.001 0.001
Data are expressed as mean  SD or as number (percentage). Total percentages do not always exactly sum to 100% because of rounding.
* Defined as self-reported medical diagnosis and/or use of any hypoglycemic medication.16
† Defined as self-reported medical diagnosis and use of antihypertensive medication and/or measured systolic blood pressure 140 mm Hg and/or diastolic blood pressure 90 mm Hg.
‡ Expressed as a percentage of the total amount of serum transferrin and defined as abnormal if 1.63% according to the Central Laboratory of Lausanne University Hospital standards.
§ Expressed as a percentage of the total amount of serum transferrin and defined as abnormal if 0%.8
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Table 2
Ten-year coronary artery disease risk, cardiovascular risk factors, and high-sensitivity C-reactive protein according to alcohol consumption in the previous 7 days (n  5,769)
Characteristic Alcohol Use (Drinks in the Past Week) p Value by
ANOVA
p Value for
Trend
p1
Value*
p2
Value*
p3
Value*
0 1–6 7–13 14–20 21–27 28–34 35
n 1,555 2,051 1,135 567 241 101 119
10-year CAD risk 3.13  0.14 3.48  0.12 4.69  0.16 6.27  0.23 7.39  0.35 7.73  0.55 8.52  0.50 0.001 0.001 0.001 0.001 0.001
Systolic blood pressure
(mm Hg)
126.8  0.4 125.3  0.4 127.9  0.5 133.3  0.7 133.9  1.1 135.5  1.7 136.7  1.6 0.001 0.001 0.26 0.001 0.001
Diastolic blood pressure
(mm Hg)
78.7  0.3 78.2  0.2 79.2  0.3 82.0  0.4 83.0  0.7 84.4  1.1 83.4  1.0 0.001 0.001 0.64 0.001 0.001
Total cholesterol (mmol/L) 5.55  0.03 5.54  0.02 5.63  0.03 5.70  0.04 5.87  0.07 6.03  0.10 5.93  0.09 0.001 0.001 0.36 0.001 0.001
HDL cholesterol (mmol/L) 1.63  0.01 1.66  0.01 1.65  0.01 1.63  0.02 1.60  0.03 1.65  0.04 1.66  0.04 0.18 0.80 0.04 0.79 0.41
LDL cholesterol (mmol/L)† 3.32  0.02 3.30  0.02 3.37  0.03 3.42  0.04 3.53  0.06 3.61  0.09 3.38  0.09 0.001 0.005 0.86 0.001 0.54
Triglycerides (mmol/L)‡ 1.14  1.01 1.10  1.01 1.19  1.02 1.25  1.02 1.44  1.03 1.43  1.05 1.60  1.05 0.001 0.001 0.58 0.001 0.001
Total cholesterol/HDL
cholesterol
3.62  0.03 3.56  0.03 3.64  0.03 3.72  0.05 3.93  0.07 3.87  0.11 3.88  0.10 0.001 0.001 0.30 0.001 0.02
hs-CRP (mg/L)‡§
Women 1.58  1.03 1.27  1.03 1.17  1.05 1.27  1.10 1.31  1.18 0.95  1.37 0.94  1.37 0.001 0.08 0.001 0.008 0.11
Men 1.33  1.05 1.07  1.04 1.16  1.04 1.49  1.05 1.39  1.08 1.55  1.12 1.62  1.11 0.001 0.001 0.002 0.14 0.09
Data are expressed as mean  SE.
* Nondrinkers and moderate, high, and very high alcohol consumption groups were defined according to previous research4,5: nondrinkers  0 drinks/week, moderate  1 to 13 drinks/week, high  14
to 34 drinks/week, and very high (35 drinks/week); p1, comparing moderate drinkers with nondrinkers; p2, comparing high drinkers with nondrinkers; p3, comparing very high drinkers with nondrinkers.
† LDL cholesterol values were not calculated when triglycerides were 4.5 mmol/L.
‡ Triglycerides and hs-CRP levels were log transformed for statistical analysis because the distributions were skewed.
§ The p value for interaction by gender was statistically significant for hs-CRP (p  0.03) in the multivariate model.
ANOVA  analysis of variance.
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Table 3
Adjusted 10-year coronary artery disease risk, cardiovascular risk factors, and high-sensitivity C-reactive protein according to alcohol consumption in the previous 7 days (n  5,769)
Characteristic Alcohol Use (Drinks in the Past Week) p Value by
ANOVA
p Value for
Trend
p1
Value*
p2
Value*
p3
Value*
0 1–6 7–13 14–20 21–27 28–34 35
n 1,555 2,051 1,135 567 241 101 119
10-year CAD risk 4.31  0.10 4.19  0.09 4.03  0.12 4.25  0.17 4.56  0.26 4.60  0.39 4.90  0.37 0.001 0.03 0.16 0.70 0.12
Systolic blood pressure (mm
Hg)†
127.4  0.4 126.4  0.3 127.5  0.4 130.9  0.6 131.4  1.0 132.7  1.5 132.2  1.4 0.001 0.001 0.16 0.001 0.001
Diastolic blood pressure
(mm Hg)†
78.7  0.3 78.7  0.2 79.2  0.3 81.3  0.4 82.2  0.7 83.4  1.0 81.7  0.9 0.001 0.001 0.67 0.001 0.002
Total cholesterol (mmol/L)‡ 5.52  0.03 5.56  0.02 5.65  0.03 5.69  0.04 5.88  0.06 6.04  0.10 5.95  0.09 0.001 0.001 0.03 0.001 0.001
HDL cholesterol (mmol/L)‡ 1.57  0.01 1.62  0.01 1.67  0.01 1.73  0.02 1.76  0.02 1.84  0.04 1.88  0.03 0.001 0.001 0.001 0.001 0.001
LDL cholesterol (mmol/L)‡,§ 3.33  0.02 3.34  0.02 3.37  0.03 3.35  0.04 3.45  0.06 3.52  0.09 3.31  0.08 0.001 0.27 0.62 0.15 0.72
Triglycerides (mmol/L)‡, 1.17  1.01 1.15  1.01 1.17  1.01 1.16  1.02 1.27  1.03 1.24  1.05 1.32  1.05 0.001 0.001 0.31 0.44 0.01
Total cholesterol/HDL
cholesterol
3.73  0.03 3.67  0.02 3.58  0.03 3.48  0.04 3.56  0.07 3.46  0.10 3.41  0.09 0.001 0.001 0.003 0.001 0.001
hs-CRP mg/L,¶
Women 1.41  1.03 1.35  1.03 1.26  1.05 1.36  1.08 1.43  1.16 0.98  1.32 1.09  1.32 0.001 0.19 0.10 0.53 0.34
Men 1.32  1.05 1.14  1.04 1.19  1.04 1.42  1.05 1.25  1.07 1.40  1.11 1.34  1.10 0.001 0.21 0.02 0.57 0.86
Data are expressed as mean  SE and were adjusted for age, gender, education, units of weekly physical activity, tobacco use, and BMI.
* Nondrinkers and moderate, high, and very high alcohol consumption groups were defined according to previous research4,5: nondrinkers  0 drinks/week, moderate  1 to 13 drinks/week, high  14
to 34 drinks/week, and very high (35 drinks/week); p1, comparing moderate drinkers with nondrinkers; p2, comparing high drinkers with nondrinkers; p3, comparing very high drinkers with nondrinkers.
† Blood pressure values were adjusted for age, gender, education, units of weekly physical activity, BMI, antihypertensive medication, and tobacco use.
‡ Lipid values were adjusted for age, gender, education, units of weekly physical activity, BMI, statins, and tobacco use.
§ LDL cholesterol values were not calculated when triglycerides were 4.5 mmol/L.
 Triglyceride and hs-CRP levels were log transformed for statistical analysis because the distributions were skewed.
¶ The p value for interaction by gender was statistically significant for hs-CRP (p  0.03) in the multivariate model.
BMI  body mass index. Other abbreviation as in Table 2.
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365Preventive Cardiology/Alcohol and Cardiovascular Risklassification was used: nondrinkers (0 drinks/week), mod-
rate (1 to 13 drinks/week), high (14 to 34 drinks/week),
nd very high (35 drinks/week) alcohol consumption.4,6
hree different types of alcoholic beverages were consid-
red in this study: wine, beer, and spirits.7 Self-reported
lcohol consumption was partially validated by measuring
he blood levels of carbohydrate-deficient transferrin (CDT;
combination of asialotransferrin and disialotransferrin).
DT separation was obtained by capillary electrophoresis
n a P/ACE 5510 System (Beckman Coulter Instruments,
yon, Switzerland). Normal CDT was defined as 1.63%,
cut-off value that included the 97.5th percentile of the
bstinent and of the “social drinker” populations (consump-
ion 30 g ethanol/day). Normal asialotransferrin was de-
ned as a level of 0%, because detectable values enable the
dentification of chronic and abusive alcohol consumption.8
e examined the relation between alcohol consumption and
DT and asialotransferrin. We did not exclude participants
ith high CDT who reported no alcohol consumption, be-
ause the specificity of CDT is 92% for alcohol consump-
ion.8
According to their smoking histories, participants were
lassified as never, current, or former smokers (if they had
topped smoking). Blood pressure and heart rate were mea-
ured by trained field investigators, 3 times in the left arm in
he seated position, after 10 minutes of rest, using an
mron HEM-907 automated oscillometric sphygmoma-
ometer (Omron Matsusaka Company, Ltd., Kyoto, Japan),
ith an appropriately sized cuff. The second and third
easurements were averaged to reduce variability, as rec-
mmended.9 Hypertension was defined as self-report and
he use of antihypertensive medications and/or measured
ystolic blood pressure 140 mm Hg and/or diastolic blood
ressure 90 mm Hg. Total and high-density lipoprotein
HDL) cholesterol were measured after overnight fasting by
nzymatic methods (cholesterol oxidase; Roche Diagnostics
mbH, Mannheim, Germany). Low-density lipoprotein
LDL) cholesterol was calculated by the Friedewald equa-
ion. Triglycerides were assessed by glycerol phosphate
xidase-p-aminophenazone. Glucose was measured by glu-
ose dehydrogenase. Hs-CRP was assessed by immunoas-
ay (HS Latex; Diagnostic Products Corporation, Los An-
eles, California). Most biologic assays were performed by
he Central Laboratory of Lausanne University Hospital,
hich is regularly checked for performance and quality. As
n other studies,10 we calculated 10-year CAD risk for each
articipant using the Framingham risk score.11 This version
f the Framingham risk score includes diabetes mellitus and
stimates the risk for CAD (angina pectoris, recognized and
nrecognized myocardial infarction, coronary insufficiency,
nd CAD death). The Framingham risk score has the best
rospective validation in several American12 and interna-
ional13 cohorts. In this version of the Framingham risk
core, diabetes was defined as fasting blood glucose level
7.8 mmol/L or receiving antidiabetic treatment.
Self-reported level of education was used as a proxy for
ocioeconomic status, a validated proxy measure in Swit-
erland.14 Physical activity was assessed by questions fo-
using on walking and other types of exercises in minutes
er week. Weight was measured in kilograms with 0.1 kg
recision using a Seca scale (Seca, Reinach, Switzerland) what was regularly calibrated. Height was measured using a
eca height gauge with a precision of 0.5 cm.
Statistical analyses were conducted using Stata version
.2 (StataCorp LP, College Station, Texas). Results are
eported as mean  SE or as numbers and percentages of
ubjects. A p value 0.05 was considered to represent
tatistical significance. Linear regression models were used
o assess the unadjusted associations between alcohol cate-
ories and blood pressure, lipids, hs-CRP, and 10-year CAD
isk. To assess other factors independently associated with
lcohol consumption, the multivariate models further in-
luded potential confounders identified by comparing base-
ine characteristics across alcohol use categories: age, gen-
er, education, tobacco use, and body mass index, as in
ther studies.15 Antihypertensive medications and statins
ere also included as confounders for blood pressure and
ipid levels, respectively. Physical activity was also in-
luded as a potential confounder on the basis of clinical
lausibility, despite a lack of significant differences. We
sed chi-square tests for trend for categorical variables and
ests for trend for continuous variables across alcohol use
ategories.5 Because a significant gender-by-alcohol inter-
ction was found for hs-CRP (p for interaction  0.03), the
esults for hs-CRP were stratified by gender. A gender-by-
lcohol interaction was also found for LDL cholesterol (p
.03), but no gender stratification was performed because no
ignificant gender-by-alcohol interactions were found for
ther lipid values. The effects of the type of alcoholic
everage on cardiovascular risk factors, 10-year CAD risk,
nd hs-CRP were assessed, generating 3 variables, wine,
eer, and spirits, corresponding to their consumption in
rinks per week. If no drink was consumed, the variable was
et to 0. The 3 variables for the type of alcoholic beverage
igure 1. Association between alcohol consumption, cardiovascular risk
actors, and 10-year CAD risk. HDL cholesterol, systolic blood pressure
BP), and 10-year CAD risk according to last week alcohol consumption.
alues are adjusted for age, gender, education, units of weekly physical
ctivity, tobacco use, body mass index, statins (for HDL cholesterol), and
ntihypertensive medications (for systolic BP). Alcohol consumption was
ssociated with increased HDL cholesterol (p for trend 0.001), systolic
P (p for trend 0.001), and 10-year CAD risk (p for trend  0.03).ere used simultaneously in a multivariate model testing
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366 The American Journal of Cardiology (www.AJConline.org)he hypothesis of the equality of the different standardized
egression coefficients for each beverage type.7 The stan-
ardized regression coefficients represent the change in the
ependent variables that resulted from a change of 1 SD in
ach of the independent variables.
esults
The baseline characteristics of the participants are listed
n Table 1. About three quarters of the participants (73%)
onsumed alcohol, and more than half (55%) had moderate
onsumption (1 to 13 drinks/week); 16% had high con-
umption (14 to 34 drinks/week), and 2% had very high
onsumption (35 drinks/week). Wine was the most fre-
uent beverage type consumed, and beer consumption was
redominant in men. Women were less likely to be in the
igh or very high alcohol consumption groups and, overall,
ended to drink less alcohol than men. Higher alcohol con-
umption was associated with increased levels of CDT and
sialotransferrin, tobacco smoking, and hypertension (all p
alues for trend 0.001).
In unadjusted analysis (Table 2), increasing alcohol use
as associated with increasing systolic and diastolic blood
ressure, total cholesterol, the ratio of total to HDL choles-
erol, LDL cholesterol, triglycerides, and 10-year CAD risk.
significant positive relation between alcohol use and
s-CRP was also found in men, but not in women (inverse
onsignificant trend). No significant relation was found be-
ween alcohol consumption and HDL cholesterol level.
In multivariate analysis, alcohol consumption was asso-
iated with increased systolic and diastolic blood pressure,
otal and HDL cholesterol, the ratio of total to HDL cho-
able 4
djusted 10-year coronary artery disease risk, cardiovascular risk factors,
onsumption in the previous 7 days
ariable Wine
0-year CAD risk 0.01  0.01
lood pressure (mm Hg)†
Systolic 0.05  0.02‡
Diastolic 0.08  0.02§
ipids (mmol/L)
Total cholesterol 0.10  0.02§
HDL cholesterol 0.18 0.02§
LDL cholesterol¶ 0.02  0.02
Triglycerides# 0.01  0.02
s-CRP (mg/L)#
Women 0.05  0.02**
Men 0.03  0.02
Data are expressed as standardized slopes per drink consumed per wee
ctivity, tobacco use, and BMI. Only participants with alcohol consumpti
* Test for the homogeneity of slopes (wine  beer  spirits).
† Blood pressure values were adjusted for age, gender, education, units
‡ p 0.01.
§ p 0.001.
 Lipid values were adjusted for age, gender, education, units of weekly
¶ LDL cholesterol values were not calculated when triglycerides were 
# Triglyceride and hs-CRP levels were log transformed for statistical an
** p 0.05.
Abbreviations as in Tables 2 and 3.esterol, triglycerides, and 10-year CAD risk (Table 3). bonversely, no significant trend was found for LDL cho-
esterol levels, nor for hs-CRP levels, but only in men. In
omen, hs-CRP was inversely associated with alcohol con-
umption, although the levels observed in the 2 highest
onsumption groups should be interpreted with caution be-
ause of the small numbers (Table 1). Restricting the anal-
sis to nonsmoking participants provided similar results
not shown). The confounding factors responsible for the
hanges in the relation between alcohol consumption and
ardiovascular risk factors were as follows: for HDL cho-
esterol, body mass index, physical activity and smoking;
or LDL cholesterol, gender and age; and for hs-CRP, body
ass index in women and smoking (major effect) and age in
en. The association between alcohol consumption and
0-year CAD risk and systolic blood pressure showed a
-shaped relation (Figure 1), while the levels of HDL cho-
esterol increased monotonically with the level of alcohol
onsumption. Excluding subjects with diabetes led to sim-
lar results. Removing from the multivariate model tobacco
se (which is used in the Framingham risk score) yielded a
imilar pattern of association between alcohol consumption
nd 10-year CAD risk.
The effects of wine, beer, and spirits on each cardiovas-
ular risk factor and 10-year CAD risk were assessed by
ultivariate analysis separately for each beverage type (Ta-
le 4). The standardized regression slopes correspond to the
ariation in cardiovascular risk factors, 10-year CAD risk,
r hs-CRP for 1 additional drink per week for each beverage
ype. The relation between alcohol and 10-year CAD risk
core did not differ by beverage type. For HDL cholesterol,
ncreased consumption of wine had a stronger effect than
hat of beer, and spirits had no effect. Similarly, wine and
gh sensitivity C-reactive protein according to beverage type
Beer Spirits p Value*
.00  0.01 0.02  0.01 0.64
.07  0.02§ 0.01  0.01 0.04
.06  0.02§ 0.00  0.02 0.001
.06  0.02‡ 0.02  0.02 0.02
.05  0.02‡ 0.01  0.01 0.001
.00  0.02 0.00  0.02 0.71
.07  0.02§ 0.04  0.02** 0.005
.00  0.02 0.02  0.02 0.08
.04  0.02 0.02  0.02 0.10
7 and were adjusted for age, gender, education, units of weekly physical
drinks/week were included in this analysis.
ly physical activity, BMI, antihypertensive medication, and tobacco use.
al activity, BMI, statins, and tobacco use.
mol/L.
ecause the distributions were skewed.and hi
0
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0
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on 7
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367Preventive Cardiology/Alcohol and Cardiovascular Riskotal cholesterol (all p values of equality of slopes 0.04).
he level of triglycerides increased with beer or spirits
onsumption but not with wine. No statistically significant
ifferences regarding the effects of each type of alcoholic
everage were found for other factors.
iscussion
In this population-based study including a substantial
roportion of high drinkers, increasing alcohol consumption
as associated with higher HDL cholesterol levels but also
ith increased levels of total cholesterol and triglycerides
nd increased blood pressure values, resulting in a J-shaped
elation with 10-year CAD risk. The protective effect of
lcohol on CAD risk disappears because the increase in
lood pressure offsets the benefits of the increase in HDL
holesterol.
A previous cross-sectional study conducted in women in
he United Kingdom5 found a linear decrease in 10-year
AD risk with average alcohol consumption up to 21
rinks/week but could not examine the effects of higher
mounts because of the very small number of participants
eporting higher consumption. A study that pooled cohort
tudies conducted in Denmark17 showed a lower risk for
eath from CAD with increasing alcohol consumption, al-
hough the effects were different according to beverage
ype: beyond 21 drinks/week, a further decrease of CAD
isk was found only for wine, but higher consumption was
ot further stratified. The Danish study also showed that
ine drinkers had lower mortality from both CAD and
ancer than nonwine drinkers. The discrepancy between our
esults and those from the United Kingdom5 and Denmark17
or wine drinkers might be explained by the wider range of
lcohol consumption (through 35 drinks/week) included in
ur study: more subjects were consequently classified as
eavy drinkers (i.e., more subjects had high CAD risk). In
enmark (as in other northern European countries), these
esults might also partially be related to the different (and
robably healthier) lifestyle of the wine drinkers.18
In the present study, we found that the J-shaped relation
etween increasing alcohol consumption and 10-year CAD
isk was most likely related to the moving balance of the
ffects of alcohol consumption. The main mechanism is
elated to HDL cholesterol and blood pressure: as alcohol
onsumption increases, the protective effect of an increas-
ng HDL cholesterol level is progressively outweighed by
he deleterious effect of increased blood pressure levels. A
revious prospective cohort study conducted in Scottish
en2 suggested that the high CAD mortality in heavy drink-
rs (15 drinks/week) was related to the effect of blood
ressure.
The increase in HDL cholesterol level with total alcohol
onsumption has been previously described7,19 and is pre-
umed to be the main mechanism for the protective effect of
oderate alcohol consumption on CAD.19 In this study,
ncreasing wine consumption was more related to increased
DL cholesterol level. The direct link between wine and
DL cholesterol level is in agreement with some studies7,20
ut not with others.21 Possible main confounders include the
igher socioeconomic status or the healthier behaviors of
ine drinkers21 or the fact that the major beverage typeonsumed by a population, wine in this population, has
ften been shown to have the strongest and most significant
ssociation with cardiovascular risk factors.22
In the present data, alcohol consumption was positively
elated to triglyceride levels, in agreement with some stud-
es23 but not with others.5,20 Multivariate analysis showed
o effect of wine on triglycerides but did show effects of
pirits and beer, similar to previous studies.7,21 However,
esidual confounding due to incomplete adjustment cannot
e ruled out, and further studies are needed to better assess
he specific effects of beverage types on triglyceride levels.
The direct association between the level of alcohol con-
umption and blood pressure is in agreement with previous
esearch,7,20 and this study provides additional information
n the effect of high levels of alcohol consumption.
hether the type of alcoholic beverage matters is still
ebated.7,24 In the present study, wine and beer exerted
imilar effects on blood pressure.
In the present data, an inverse relation between alcohol
onsumption and hs-CRP levels was found in women, albeit
ot statistically significant, whereas a more complex J-
haped relation was found in men. The decrease in hs-CRP
evels with increased alcohol consumption in women is in
greement with previous studies, whereas the lack of de-
rease in male alcohol drinkers does not reproduce previous
eports,25,26 which might be related to the highest consump-
ion groups in our population. Indeed, in previous studies,25
he inverse relation between alcohol consumption and hs-
RP levels was found in drinkers of 1 to 7 drinks/week,
hereas an increase in hs-CRP levels was found for higher
evels of consumption. Overall, our data suggest that the
eneficial effect of alcohol consumption on hs-CRP levels
ight actually disappear and become deleterious for levels
f consumption2 drinks/day. We found no major effect of
everage type, in agreement with a study in Chile.27
Our study had several limitations. First, alcohol con-
umption was self-reported, which might lead to the selec-
ive misclassification of heavy drinkers. However, data on
lcohol consumption from food-frequency questionnaires
nd 1-week diet records have been shown to be well corre-
ated,28 and most studies on alcohol consumption have re-
ied on self-reported data.2,7 Moreover, the present study
sed CDT levels to help validate reported alcohol consump-
ion. The use of a recall period limited to 1 week before the
urvey interview might also lead to the misclassification of
ome participants who do consume alcohol but who did not
rink in the previous 7 days. Although this may artificially
ncrease the proportion of abstainers, short recall periods
ave been consistently shown to be better than long periods
o assess consumption at higher levels.29 Another limitation
s that our study did not capture drinking patterns, such as
inge drinking. Finally, the 10-year CAD risk did not ac-
ount for other potential beneficial effects of alcohol on
ariables that are not included in the Framingham risk score,
uch as fibrinogen.30
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